Eczematous reaction to IVIG for the treatment of dermatomyositis

Eczematous reaction to IVIG for the treatment of dermatomyositis

The use of high-dose intravenous immunoglobulin (IVIG) is an accepted therapy for patients with refractory dermatomyositis. Cases of eczematous reactions to IVIG have been reported in the literature, but to our knowledge, none in patients being treated for dermatomyositis. We report on the cases of...

Full description

Bibliographic Details
Main Authors:	J. Berk-Krauss, K. Lee, K.I. Lo Sicco, T.N. Liebman
Format:	Article
Language:	English
Published:	Wolters Kluwer 2018-09-01
Series:	International Journal of Women's Dermatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352647518300157

Similar Items

Case report: Eczematous adverse drug reaction after selpercatinib treatment
by: Bingrun Li, et al.
Published: (2024-12-01)

An eczematous eruption on the arm
by: Kazunari Sugita, et al.
Published: (2021-01-01)

Efficacy of topical Doxepin in the treatment of eczematous dermatoses
by: Samaresh Chandra Hazra, et al.
Published: (2013-02-01)

Atopic dermatitis and eczematous disorders /
by: Rudikoff, Donald, editor, et al.
Published: (2014)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
by: Merav Koschitzky, BA, et al.
Published: (2021-05-01)

Subcutaneous immunoglobulin-induced eczematous dermatitis
by: Rachel Breidbart, BS, et al.
Published: (2025-02-01)

Eczematous skin lesion with nipple destruction
by: Arun C Inamadar
Published: (2012-01-01)

Persistent eczematous lesions over the body
by: Ramesh M Bhat, et al.
Published: (2014-01-01)

Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
by: Michael P. Salna, et al.
Published: (2017-01-01)

Treatment of scleromyxedema with IVIg
by: Moser David W, et al.
Published: (2012-07-01)

Two cases of eczematous eruptions caused by everolimus
by: Minako Habu, et al.
Published: (2019-10-01)

Severe eczematous dermatitis with hyperimmunoglobulin E syndrome
by: Raavi Ramapure, et al.
Published: (2022-01-01)

Anything Rare is Possible: Letrozole Induced Eczematous Skin Eruption
by: Amruta Tripathy, et al.
Published: (2014-06-01)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024-07-01)

Eczematous dermatitis and thrombocytopenia in a 10‐month‐old boy
by: Cristina Moya‐Martínez, et al.
Published: (2022-03-01)

Nonbullous pemphigoid representing clinical manifestation as eczematous skin eruption
by: Noriko Kagawa, et al.
Published: (2023-12-01)

Eczematous liraglutide eruption managed by dupilumab: A case report
by: Claudia Paganini, MD, et al.
Published: (2024-11-01)

Eczematous, Pruritic, Brownish Plaque of the Nipple and Areola: A Quiz
by: Gloria Orlando, et al.
Published: (2019-10-01)

Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab
by: Gennaro Marco Falco, et al.
Published: (2024-10-01)

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report
by: Camille M. Powers, et al.
Published: (2024-12-01)

MIS-C Treatment: Is IVIG Always Necessary?
by: Francesco Licciardi, et al.
Published: (2021-11-01)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
by: Zhouping Wang, et al.
Published: (2020-01-01)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
by: Daniel Gutierrez, MD, et al.
Published: (2022-04-01)

A comparative study of IVIG versus IVIG with IV methylprednisolone in guillain–barre syndrome
by: Rahi Kiran Bhattiprolu, et al.
Published: (2020-01-01)

Keratitis following leech therapy for periocular eczematous dermatitis: a case report
by: Dilek Özkaya
Published: (2023-01-01)

FLOCK -flare clock: Passive sweat-based eczematous flare detection system
by: Sayali Upasham, et al.
Published: (2022-05-01)

Successful Treatment of Scleromyxedema with IVIG: A Case Report
by: Fatemeh Niksolat, et al.
Published: (2018-05-01)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
by: Francesco Licciardi, et al.
Published: (2022-02-01)

Efficacy and safety of topical halometasone in eczematous dermatoses in Indian population: An open label, noncomparative study
by: H R Jerajani, et al.
Published: (2011-01-01)

Diagnosis and Treatment of Dermatomyositis
by: J Gordon Millichap
Published: (2006-07-01)

Progressing eczematous dermatitis in an infantile hemangioma with minimal or arrested growth treated with tacrolimus ointment
by: Raya Qais Alsaid, MD, et al.
Published: (2020-06-01)

A clinician's guide to cutaneous T-cell lymphoma presenting as recalcitrant eczematous dermatitis in adults
by: Sarah Semaan, BS, et al.
Published: (2021-09-01)

IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
by: Min Gi Sakong, et al.
Published: (2022-10-01)

Assessment of IVIG treatment in children and its complications, Babol, 1999-2004
by: E Mohammad Zadeh I, A, Atar Zadeh, et al.
Published: (2006-04-01)

IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
by: Alyssa Herrmann, et al.
Published: (2017-07-01)

The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease
by: Qiong-Qiong Wang, et al.
Published: (2023-08-01)

Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study
by: Xiao-Lu Zhu, et al.
Published: (2022-04-01)

Dermatomyositis with Eosinophils
by: Isabella I. Sanchez, et al.
Published: (2023-11-01)

Refractory eczematous dermatitis arising after allogeneic hematopoietic stem cell transplantation responsive to dupilumab
by: Jenny Lai, PhD, et al.
Published: (2024-11-01)

Obsessive – Compulsive Disorder in Eczematous Patients Referred to a Public Dermatology Clinic in Isfahan, Iran
by: Gholamreza Kheirabadi, et al.
Published: (2011-05-01)